CA
CSM Advisors’s Biogen BIIB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.45M | Sell |
27,459
-400
| -1% | -$50.2K | 0.1% | 242 |
|
2025
Q1 | $3.81M | Sell |
27,859
-300
| -1% | -$41.1K | 0.21% | 75 |
|
2024
Q4 | $4.3M | Buy |
28,159
+50
| +0.2% | +$7.64K | 0.2% | 76 |
|
2024
Q3 | $5.45M | Sell |
28,109
-300
| -1% | -$58.2K | 0.36% | 76 |
|
2024
Q2 | $6.59M | Hold |
28,409
| – | – | 0.46% | 63 |
|
2024
Q1 | $6.13M | Buy |
28,409
+270
| +1% | +$58.2K | 0.4% | 72 |
|
2023
Q4 | $7.28M | Sell |
28,139
-87
| -0.3% | -$22.5K | 0.52% | 63 |
|
2023
Q3 | $7.26M | Sell |
28,226
-590
| -2% | -$152K | 0.63% | 51 |
|
2023
Q2 | $8.2M | Sell |
28,816
-743
| -3% | -$212K | 0.62% | 47 |
|
2023
Q1 | $8.22M | Buy |
29,559
+1,800
| +6% | +$500K | 0.71% | 44 |
|
2022
Q4 | $7.69M | Sell |
27,759
-310
| -1% | -$85.8K | 0.73% | 39 |
|
2022
Q3 | $7.5M | Sell |
28,069
-9,650
| -26% | -$2.58M | 0.82% | 35 |
|
2022
Q2 | $7.69M | Buy |
37,719
+158
| +0.4% | +$32.2K | 0.7% | 43 |
|
2022
Q1 | $7.91M | Sell |
37,561
-2,900
| -7% | -$611K | 0.54% | 56 |
|
2021
Q4 | $9.71M | Sell |
40,461
-350
| -0.9% | -$84K | 0.64% | 49 |
|
2021
Q3 | $11.5M | Sell |
40,811
-10
| -0% | -$2.83K | 0.85% | 35 |
|
2021
Q2 | $14.1M | Sell |
40,821
-410
| -1% | -$142K | 0.93% | 30 |
|
2021
Q1 | $11.5M | Buy |
+41,231
| New | +$11.5M | 1.62% | 24 |
|